Literature DB >> 1929643

Constrictive pericarditis from Nocardia asteroides infection.

R Kessler1, F Follis, D Daube, J Wernly.   

Abstract

Human nocardiosis usually involves the respiratory tract or the skin but may disseminate to virtually any organ. It occurs in immunocompromised hosts as well as individuals with no apparent predisposition. Involvement of the pericardium is uncommon, having been reported infrequently in the past, but mandates surgical management. This report describes the course of a patient with chronic constrictive pericarditis from nocardia successfully treated with pericardiectomy and appropriate antibiotic therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1929643     DOI: 10.1016/0003-4975(91)91228-n

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Nocardia pericarditis.

Authors:  S J Tabrizi
Journal:  BMJ       Date:  1994-12-03

Review 2.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 3.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Rare case of Nocardia asteroides pericarditis in a human immunodeficiency virus-infected patient.

Authors:  Sadao Jinno; Tanawat Jirakulaporn; Matthew J Bankowski; Wesley Kim; Russell Wong
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

Review 5.  Nocardia mikamii a Novel Species Causing Disseminated Nocardiosis: A Literature Review of Disseminated Nocardiosis.

Authors:  Muhammad Khan; Mohammed Muqeet Adnan; Najmi Shahbaz; Muhammad Hamza; Sufyan Abdul Mujeeb
Journal:  Int Sch Res Notices       Date:  2014-10-16

Review 6.  Isolated Nocardiosis, an Unrecognized Primary Immunodeficiency?

Authors:  Rubén Martínez-Barricarte
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.